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and exit) were below 10 % (TLD and SEM
detectors) with the exceptions for the neck
at lateral and for the lungs at AP/PA fields
where the errors exceeded 10 %.
Conclusions: For the group of patients
the per cent deviations exceeded 10%
for the neck exit in lateral fields and for
the lung exit in anterior - posterior fields.
Standard deviations exceeded 10%
at the neck and lung exits in lateral fields
and at the lung exit in anterior - posterior
fields.
5.
SEDIMENTATION AS EFFECTIVE
METHOD OF PRELIMINARY ISOLATION
OF STEM CELLS FROM CORD BLOOD
J. Antoniewicz-Papis, A. Dzieciqtkowska,
E. Lachert, I. Kopec, M. t~towska,
U. Podstawka, D. Apel, B. Marianska,
J. Sablinski1
Cord Blood Bank
Institute of Hematology and Blood
Transfusion, Warsaw, Poland
Cord blood is a rich source of primitive
hemopoietic stem cells. In clinical hema-
tology it is transplanted instead of bone
marrow or peripheral blood stem cells.
The Institute of Hematology and Blood
Transfusion in Warsaw has had a Cord
Blood Bank (WACB) since 1997. WACB
collaborates with Eurocord Transplant
Group and with Bone Marrow Donors
Worldwide transfering data on frozen CB
intended for transplantation. During 1997 -
2000, a total of 159 unrelated and 29 re-
lated cord blood units were collected.
More than 70% of transplants of CB were
perfomed in pediatric recipiens it is nece-
ssary to reduce its volume of storage
of CB units. Separation techniques reduce
sample volume to ± 20 ml. Sedimentation
methods reduce the number of RBC to be
infused. RBC depletion reduces the risk
of incompatibile reaction. Sedimentation
reduces side-effects of the DMSO (dimethyl
sulfoxide) cytotoxity (DMSO volume is re-
duced to 4 ml).
The aim of our study was to evaluate
methods of isolating leukocytes from cord
blood within a closed system. Two me-
thods of isolation have been tested: 6%
hydroxyethyl starch in 0,9% NaCI and 3%
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gelatin in 0,9% NaCI (Gelafundine, Braun).
Centrifugation and sedimentation methods
have been used. The final volume of cord
blood was 20 ml for each unit. The best
results were obtained for sedimentation.
With 3% gelatin sedimentation 75,1%
WBC and 81,3% CD34+ were recovered,
while the waste of RBC was 97,2%;
with 6% HES sedimentation the results
were: 65%; 90,3%, and 80,5% respe-
ctively. The results of our centrifugation
methods revealed a great loss of proge-
nitor cells (approx. 40%). 6% HES and 3%
gelatin are approved for clinical use,
therefore sedimentation methods based
on these media are safe for recipients.
Furthermore, the use of closed system
recommended by Eurocord Transplant,
prevents bacterial contamination.
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Purpose: We present the role of detailed
and frequent monitoring of hematopoietic
chimerism in prediction of post-transplant
clinical outcome and our initial experience
with adoptive immunotherapy (AI) in pre-
vention and treatment of relapse in children
after allogeneic hematopoietic stem cell
transplantation (HSCT) for leukemia.
Materials and methods: Between
1/1997 and 12/2000 we performed a total
of 46 unmanipulated allogeneic HSCT
from HLA-identical siblings (MSD;23)
or matched unrelated donors (MUD;23)
in 43 consecutive children with hema-
tological malignancies (ALL 16, AML 15,
CML 5, MDS 6, JMML 3, CMML 1) with
a median age of 10,5 years. We have
analyzed hematopoietic chimerism in peri-
pheral blood samples using polymerase
chain reaction (peR) of variable number
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